Estrogen Receptor β as a Prognostic Marker of Tumor Progression in Colorectal Cancer with Familial Adenomatous Polyposis and Sporadic Polyps

Estrogen Plus Progestin and Colorectal Cancer Incidence and Mortality

(2012) Michael S. Simon et al.   JOURNAL OF CLINICAL ONCOLOGY

Global cancer statistics

(2011) Ahmedin Jemal et al.   CA-A CANCER JOURNAL FOR CLINICIANS

Menopausal hormone therapy and risk of gastrointestinal cancer: Nested case-control study within a prospective cohort, and meta-analysis

(2011) Jane Green et al.   INTERNATIONAL JOURNAL OF CANCER

The effect of estrogen vs. combined estrogen-progestogen therapy on the risk of colorectal cancer

(2011) Kueiyu Joshua Lin et al.   INTERNATIONAL JOURNAL OF CANCER

HER2 diagnostics in gastric cancer—guideline validation and development of standardized immunohistochemical testing

(2010) Josef Rüschoff et al.   VIRCHOWS ARCHIV

Use of Hormone Replacement Therapy and the Risk of Colorectal Cancer

(2009) Gad Rennert et al.   JOURNAL OF CLINICAL ONCOLOGY

Correlated downregulation of estrogen receptor beta and the circadian clock gene Per1 in human colorectal cancer

(2009) Nazanin Mostafaie et al.   MOLECULAR CARCINOGENESIS

Ligand-dependent interaction between estrogen receptor and adenomatous polyposis coli

(2008) Alexander P. Kouzmenko et al.   GENES TO CELLS

Guidelines for the clinical management of familial adenomatous polyposis (FAP)

(2008) H. F. A. Vasen et al.   GUT

Oestrogen and the colon: potential mechanisms for cancer prevention

(2008) Rory Kennelly et al.   LANCET ONCOLOGY